LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Clinical trials for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL SQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep early lung cancer from returning
Disease control OngoingThis study tests whether adding an immunotherapy drug (nivolumab) to precise, high-dose radiation (SABR) helps keep early-stage non-small cell lung cancer from coming back. About 140 people with stage I-IIA or recurrent lung cancer will be randomly assigned to get radiation alone…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:30 UTC
-
New drug cocktail shows promise for tough lung cancer
Disease control OngoingThis study is for people with advanced squamous non-small cell lung cancer that has spread. It tests a new drug called berzosertib added to standard chemotherapy and immunotherapy. The goal is to find the safest dose and see if the combination helps keep the cancer from growing l…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC